HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamide

prostaglandin H synthase-2 inhibitor
Also Known As:
JTE 522; JTE-522
Networked: 35 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kawauchi, Akihiro: 3 articles (01/2010 - 12/2002)
2. Miki, Tsuneharu: 3 articles (01/2010 - 12/2002)
3. Mizutani, Yoichi: 3 articles (01/2010 - 12/2002)
4. Hirakawa, Kosei: 3 articles (02/2007 - 08/2002)
5. Fukushima, Shoji: 3 articles (01/2005 - 12/2003)
6. Salim, Elsayed I: 3 articles (01/2005 - 12/2003)
7. Shen, Jun: 3 articles (01/2005 - 12/2003)
8. Wanibuchi, Hideki: 3 articles (01/2005 - 12/2003)
9. Wei, Min: 3 articles (01/2005 - 12/2003)
10. Murawaki, Yoshikazu: 2 articles (05/2010 - 11/2007)

Related Diseases

1. Carcinogenesis
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Colonic Neoplasms (Colon Cancer)
5. Colorectal Neoplasms (Colorectal Cancer)

Related Drugs and Biologics

1. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
2. 1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
3. Dimenhydrinate (DMH)
4. Cyclooxygenase 2 (Cyclooxygenase-2)
5. Dinoprostone (PGE2)
6. Proteins (Proteins, Gene)
7. N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
8. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
9. Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
10. Indomethacin (Indometacin)

Related Therapies and Procedures

1. Therapeutics
2. Combination Drug Therapy (Combination Chemotherapy)
3. Aftercare (After-Treatment)
4. Oral Administration